Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Hepatocellular Carcinoma Treatment and Prognosis
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the management, diagnosis, and treatment of hepatocellular carcinoma (HCC), also known as liver cancer. It covers various aspects including clinical practice guidelines, radiofrequency ablation, use of sorafenib, liver resection, and survival rates.
130,080
Works
2,392,127
Citations
IDs:OpenAlex
How has Hepatocellular Carcinoma Treatment and Prognosis's publication output changed over time?
ScholarIQpublication output · 2018
1
2018
Who are the most-cited researchers behind Hepatocellular Carcinoma Treatment and Prognosis?
ScholarIQtop researchers by citations
What are the most-cited papers on Hepatocellular Carcinoma Treatment and Prognosis?
ScholarIQmost cited works
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Andrea L. Webber, Scot Ebbinghaus, Junshui Ma, Abby B. Siegel, Ann‐Lii Cheng, Masatoshi Kudo, Angela Alistar, Jamil Asselah, Jean‐Frédéric Blanc, Ivan Borbath, Timothy Lewis Cannon, Ki Y. Chung, Allen Lee Cohn, David Cosgrove, Nevena Damjanov, Mukul Gupta, Yoshivasu Karino, Mark Karwal, Andreas Kaubisch, Robin Kate Kelley, Jena-Luc Van Laethem, Timothy Larson, James Lee, Daneng Li, Atisha Manhas, Gulam A. Manji, Kazushi Numata, Benjamin M. Parsons, Andrew Scott Paulson, Carmine Pinto, Robert A. Ramirez, Suresh Ratnam, Magnus Rizell, Olivier Rosmorduc, Yvonne H. Sada, Yutaka Sasaki, Per Stål, Simone I. Strasser, Joerg Trojan, Gina M. Vaccaro, Hans Van Vlierberghe, Alan Weiss, Karl-Heinz Weiss, Tatsuya Yamashita
The Lancet Oncology. 20182,543 Citations
Where is Hepatocellular Carcinoma Treatment and Prognosis research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
The Lancet Oncology2,543
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Hepatocellular Carcinoma Treatment and Prognosis is open access?
ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%
Who collaborates most closely around Hepatocellular Carcinoma Treatment and Prognosis?
ScholarIQco-authorship network
United States
45%
South Korea
18%
France
18%
Canada
9%
Italy
9%